XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer

The aim of this study was to compare the efficacy, safety and survival rate of a treatment regimen comprising capecitabine plus irinotecan (XELIRI) to those of a standard regimen comprising leucovorin, fluorouracil and irinotecan (FOLFIRI), to determine the correlation among the inherited genetic va...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: CUI, CHENGXU, SHU, CHANG, YANG, YI, LIU, JUNBAO, SHI, SHUPING, SHAO, ZHUJUN, WANG, NAN, YANG, TING, HU, SONGNIAN
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4156196/
https://ncbi.nlm.nih.gov/pubmed/25202427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados